MEDICATION

REFERENCES

  1. Bell A, Hewins B, Bishop C, et al. Traumatic brain injury, sleep, and melatonin-intrinsic changes with therapeutic potential. Clocks Sleep. 2023;5(2):177-203. doi:10.3390/clockssleep5020016

  2. Cassimatis M, Browne G, Orr R. The utility of melatonin for the treatment of sleep disturbance after traumatic brain injury: a scoping review. Arch Phys Med Rehabil. 2023;104(2):340-349. doi:10.1016/j.apmr.2022.09.018

  3. Echeverri D, Montes FR, Cabrera M, Galán A, Prieto A. Caffeine’s vascular mechanisms of action. Int J Vasc Med. 2010;2010:834060. doi:10.1155/2010/834060

  4. Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med. 2018;16(1):8. doi:10.1186/s12916-017-0995-1

  5. Kong J, Fan R, Zhang Y, et al. Oxidative stress in the brain-lung crosstalk: cellular and molecular perspectives. Front Aging Neurosci. 2024;16:1389454. doi:10.3389/fnagi.2024.1389454

  6. Li W, Xu B, Guo Y, Raj B, Yang Y. Mitochondrial and ER stress crosstalk in TBI: mechanistic insights and therapeutic opportunities. Front Cell Neurosci. 2025;19:1697060. doi:10.3389/fncel.2025.1697060

  7. Lipton RB, Diener HC, Robbins MS, Garas SY, Patel K. Caffeine in the management of patients with headache. J Headache Pain. 2017;18(1):107. doi:10.1186/s10194-017-0806-2

  8. Lucke-Wold BP, Logsdon AF, Nguyen L, et al. Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury. Nutr Neurosci. 2018;21(2):79-91. doi:10.1080/1028415X.2016.1236174

  9. Lynch DG, Narayan RK, Li C. Multi-mechanistic approaches to the treatment of traumatic brain injury: a review. J Clin Med. 2023;12(6):2179. doi:10.3390/jcm12062179

  10. Moskatel LS, Schuster NM. Medication-overuse headache: results from a pain medicine clinic cohort. Ann Headache Med. 2021;6:03. doi:10.30756/ahmj.2021.06.03

  11. Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:580289. doi:10.3389/fphar.2020.580289

  12. Rana A, Singh S, Sharma R, Kumar A. Traumatic brain injury altered normal brain signaling pathways: implications for novel therapeutics approaches. Curr Neuropharmacol. 2019;17(7):614-629. doi:10.2174/1570159X16666180911121847

  13. Shekleton JA, Parcell DL, Redman JR, Phipps-Nelson J, Ponsford JL, Rajaratnam SMW. Sleep disturbance and melatonin levels following traumatic brain injury. Neurology. 2010;74(21):1732-1738. doi:10.1212/WNL.0b013e3181e0438b

  14. Trojian TH, Wang DH, Leddy JJ. Nutritional supplements for the treatment and prevention of sports-related concussion—evidence still lacking. Curr Sports Med Rep. 2017;16(4):247-255. doi:10.1249/JSR.0000000000000387

  15. Woo SY, Park MK, Kho AR, et al. Amlexanox ameliorates traumatic brain injury by restoring autophagy-lysosomal function via cAMP signaling modulation. Int J Biol Sci. 2025;21(10):4467-4484. doi:10.7150/ijbs.111216